90972-27-3

Basic information

• Product Name: ACETIC ACID, (2-PYRIDYLOXY)-, ETHYL ESTER
• Synonyms: ACETIC ACID, (2-PYRIDYLOXY)-, ETHYL ESTER;Ethyl 2-(pyridin-2-yloxy)acetate
• CAS NO: 90972-27-3
• Molecular Formula: C₉H₁₁NO₃
• Molecular Weight: 181.19
• Mol File: 90972-27-3.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 249.9°C at 760 mmHg
• Flash Point: 105°C
• Appearance: /
• Density: 1.134g/cm³
• Vapor Pressure: 0.0223mmHg at 25°C
• Refractive Index: 1.496
• Storage Temp.: 2-8°C
• CAS DataBase Reference: ACETIC ACID, (2-PYRIDYLOXY)-, ETHYL ESTER(CAS DataBase Reference)
• NIST Chemistry Reference: ACETIC ACID, (2-PYRIDYLOXY)-, ETHYL ESTER(90972-27-3)
• EPA Substance Registry System: ACETIC ACID, (2-PYRIDYLOXY)-, ETHYL ESTER(90972-27-3)

Safety Data

• Hazardous Substances Data: 90972-27-3(Hazardous Substances Data)

Usage

InChI:InChI=1/C9H11NO3/c1-2-12-9(11)7-13-8-5-3-4-6-10-8/h3-6H,2,7H2,1H3

Upstream product

• 142-08-5 2-Pyridone 
• 623-73-4 diazoacetic acid ethyl ester 
• 109-04-6 2-bromo-pyridine 
• 38233-96-4 ethyl 2-hydroxyacetate sodium salt 
• 142-08-5 2-hydroxypyridin 
• 105-36-2 ethyl bromoacetate 
• 105-39-5 chloroacetic acid ethyl ester 

Downstream Products

• 58530-50-0 2-(pyridin-2-yloxy)acetic acid 

Relevant articles and documents

Synthesis, structure analysis, DFT calculations and energy frameworks of new coumarin appended oxadiazoles, to regress ascites malignancy by targeting VEGF mediated angiogenesis

Ascites malignancy is a frequent cause of morbidity and presents significant management problems which occur in many cancers. Angiogenesis plays a major role in the prognosis of ascites tumor through Vascular Endothelial Growth Factor (VEGF). Inhibition o

Design and synthesis of conjugated azo-hydrazone analogues using nano BF3·SiO2 targeting ROS homeostasis in oncogenic and vascular progression

Disrupted redox balance is implicated in multiple pathologies including malignant progression and tumor angiogenesis. In this investigation, we report the design and development of novel and effective ROS detoxifying azo-hydrazone molecules targeting mali

QUINOLINONE DERIVATIVES

The present invention relates to compounds of the formula (I), salts thereof, to pharmaceutical compositions containing them and their use in medicine. In particular, the invention relates to compounds as activators of AMPK.